Rosacea: An Introduction — Help for Australians

16/5/10 — Updates to Rosacea Treatment and Rosacea Laser Treatment.

17/6/08 — Skinceuticals: Skinceuticals C F Phloretin.

30/3/08 — Updates to Rosacea Treatment and Rosacea Symptoms.

30/3/08 — Clinical Skin Care: Rosacea Sunscreens.

26/3/08 — Increased Expression of VEGF in Patients with Subtype One and Two Rosacea.

12/2/08 — Rhinophyma may increase the prevalence and obscure the detection of skin cancer.

Rosacea is a vascular, inflammatory skin disorder that affects approximately 5% of the population and is characterised by frequent periods of facial redness or flushing caused by over-active capillaries.

Over time, this chronic state of skin inflammation gives rise to a variety of rosacea symptoms.

Physicians and professionals in the field of skin care are seeing rapidly increasing numbers of individuals affected by Rosacea as the "over 40" population continues to grow and as the distinction between Acne and Rosacea is clarified by an increasing number of specialists.

The number of younger people with rosacea is also growing.

Rosacea is gaining in general public awareness as evidenced by the designation of March as "National Rosacea Awareness Month".

Rosacea is an often baffling skin disease — difficult to treat and able to cause severe emotional distress due to the visibly deteriorating facial involvement.